Holen Sie sich die Stockscreener-App
1.30
2.36%
0.03
Handel nachbörslich:
1.29
-0.01
-0.77%
Schlusskurs vom Vortag:
$1.27
Offen:
$1.3
24-Stunden-Volumen:
878.10K
Relative Volume:
0.62
Marktkapitalisierung:
$91.91M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-144.01M
KGV:
-0.3242
EPS:
-4.01
Netto-Cashflow:
$-113.02M
1W Leistung:
-5.80%
1M Leistung:
-1.52%
6M Leistung:
-28.96%
1J Leistung:
-69.56%
1-Tages-Spanne:
$1.24
$1.315
1-Wochen-Bereich:
$1.24
$1.4794
52-Wochen-Spanne:
$0.8719
$4.43
Biomea Fusion Inc Stock (BMEA) Company Profile
Firmenname
Biomea Fusion Inc
Sektor
Branche
Telefon
(650) 980-9099
Adresse
1599 INDUSTRIAL ROAD, SAN CARLOS
Vergleichen Sie BMEA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BMEA
Biomea Fusion Inc
|
1.30 | 89.79M | 0 | -144.01M | -113.02M | -4.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
474.17 | 120.98B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
771.25 | 80.15B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
864.42 | 51.56B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
354.75 | 47.74B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
336.16 | 37.38B | 4.98B | 69.59M | 525.67M | 0.5197 |
Biomea Fusion Inc Stock (BMEA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-13 | Eingeleitet | Rodman & Renshaw | Buy |
| 2025-08-28 | Eingeleitet | Jefferies | Buy |
| 2025-06-03 | Fortgesetzt | Piper Sandler | Overweight |
| 2024-10-09 | Eingeleitet | Edward Jones | Buy |
| 2024-09-27 | Hochstufung | Rodman & Renshaw | Neutral → Buy |
| 2024-09-27 | Hochstufung | Truist | Hold → Buy |
| 2024-08-29 | Eingeleitet | CapitalOne | Overweight |
| 2024-06-11 | Herabstufung | Truist | Buy → Hold |
| 2024-06-07 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2024-04-02 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-02-06 | Eingeleitet | Truist | Buy |
| 2023-07-27 | Eingeleitet | Scotiabank | Sector Outperform |
| 2023-06-26 | Herabstufung | Jefferies | Buy → Hold |
| 2023-05-12 | Eingeleitet | Barclays | Overweight |
| 2023-03-29 | Bestätigt | Oppenheimer | Outperform |
| 2023-03-28 | Bestätigt | H.C. Wainwright | Buy |
| 2023-02-24 | Eingeleitet | Citigroup | Buy |
| 2022-06-02 | Fortgesetzt | H.C. Wainwright | Buy |
| 2022-01-12 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-12-17 | Eingeleitet | Oppenheimer | Outperform |
| 2021-05-11 | Eingeleitet | JP Morgan | Overweight |
| 2021-05-11 | Eingeleitet | Jefferies | Buy |
| 2021-05-11 | Eingeleitet | Piper Sandler | Overweight |
Alle ansehen
Biomea Fusion Inc Aktie (BMEA) Neueste Nachrichten
Does Biomea Fusion Inc stock benefit from AI growth2025 Momentum Check & Consistent Return Strategy Ideas - baoquankhu1.vn
Market Catalysts: Is Biomea Fusion Inc part of any major indexJuly 2025 Rallies & Free Real-Time Volume Trigger Notifications - baoquankhu1.vn
Biomea Fusion, Inc.'s (NASDAQ:BMEA) largest shareholders are retail investors with 55% ownership, institutions own 38% - Yahoo Finance
Levels Update: Does Biomea Fusion Inc offer margin of safetyQuarterly Performance Summary & Daily Technical Stock Forecast Reports - baoquankhu1.vn
Biomea Fusion, Inc. (NASDAQ:BMEA) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Rodman & Renshaw Initiates Biomea Fusion (BMEA) at Buy with $8 Price Target - Insider Monkey
Biomea Fusion Spotlights Diabetes, Obesity Pipeline at JPMorgan Conference, Sets 2026 Milestones - MarketBeat
BMEA: Durable A1C reduction and advancing weight loss studies highlight strong clinical momentum - TradingView
Biomea Fusion Highlights Diabetes Pipeline at JPM Conference - TipRanks
Biomea Fusion, Inc. Updates on Icovamenib Clinical Progress - TradingView
Rodman & Renshaw Initiates Coverage on Biomea Fusion (NASDAQ:BMEA) - MarketBeat
Rodman & Renshaw initiates Biomea Fusion stock with Buy rating By Investing.com - Investing.com Nigeria
Rodman & Renshaw initiates Biomea Fusion stock with Buy rating - Investing.com
BMEA: Today's Analyst Rating and Price Target Update | BMEA Stoc - GuruFocus
Biomea Fusion (NASDAQ:BMEA) Given Buy Rating at D. Boral Capital - MarketBeat
Published on: 2026-01-13 19:04:12 - Bộ Nội Vụ
Biomea Fusion outlines 2026 diabetes and obesity drug development plans By Investing.com - Investing.com Nigeria
Biomea Fusion outlines 2026 diabetes and obesity drug development plans - Investing.com
Biomea Fusion Enters 2026 Focused on Executing Key Icovamenib and BMF-650 Milestones - manilatimes.net
Experimental pills for diabetes and obesity line up key 2026 tests - Stock Titan
Biomea Fusion launches public offering of stock and warrants; shares down 23% - MSN
Is Biomea Fusion Inc. stock near bottom after decline2025 Market Outlook & AI Driven Stock Reports - ulpravda.ru
Stop Loss: Is Biomea Fusion Inc. stock near bottom after declineDollar Strength & Advanced Swing Trade Entry Alerts - Улправда
Will Biomea Fusion Inc. stock return to pre crisis levels2026 world cup usa national team round of 16 key players build up play expert forecast preview - ulpravda.ru
Biomea Fusion looks to major milestones in 2026 - Traders Union
Biomea Fusion downgraded to Underweight from Neutral at JPMorgan - MSN
Biomea Fusion Inc. (BMEA) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Biomea Fusion, Inc. (NASDAQ:BMEA) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Biomea Fusion explores challenges of insulin therapy - Traders Union
Can Biomea Fusion Inc. stock outperform in 2025 bull marketCEO Change & Detailed Earnings Play Strategies - Улправда
Published on: 2025-12-20 18:19:39 - Улправда
How interest rate cuts could boost Biomea Fusion Inc. stockWeekly Stock Recap & Daily Momentum Trading Reports - Улправда
Published on: 2025-12-20 15:52:57 - Улправда
Will Biomea Fusion Inc. stock split attract more investors2025 Technical Overview & Technical Entry and Exit Alerts - DonanımHaber
Published on: 2025-12-19 02:18:12 - Улправда
Aug Closing: Will Biomea Fusion Inc. stock outperform growth indexesJuly 2025 Action & Risk Controlled Swing Alerts - Улправда
Gap Down: Can Biomea Fusion Inc. stock outperform in 2025 bull market - Улправда
Biomea Fusion, Inc.(NasdaqGS: BMEA) dropped from NASDAQ Biotechnology Index - marketscreener.com
Biomea Fusion to Present at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Biomea Fusion presents COVALENT-111 study results at WCIRDC - MSN
Insider Buying: Biomea Fusion (NASDAQ:BMEA) Insider Acquires 30,000 Shares of Stock - MarketBeat
Biomea Fusion Director Rainer M Erdtmann Acquires 30,000 Shares - TradingView — Track All Markets
[Form 4] Biomea Fusion, Inc. Insider Trading Activity - Stock Titan
JANUS HENDERSON GROUP PLC Acquires Significant Stake in Biomea F - GuruFocus
Interim CEO & Director of Biomea Fusion Michael J. Hitchcock Buys 667% More Shares - simplywall.st
Biomea Fusion Announces KOL Presentation and Interview on Menin and Icovamenib at WCIRDC 2025 - The Manila Times
Biomea Fusion Highlights the Future of Menin Inhibitors and Icovamenib in Interview with Dr. Ralph DeFronzo at WCIRDC 2025 - Quiver Quantitative
Finanzdaten der Biomea Fusion Inc-Aktie (BMEA)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.09%
0.48%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):